Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $48.8 million.

  • Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) fell 185.07% to $48.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $48.8 million, marking a year-over-year decrease of 185.07%. This contributed to the annual value of $49.7 million for FY2025, which is 12.06% down from last year.
  • Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) amounted to $48.8 million in Q4 2025, which was down 185.07% from $49.2 million recorded in Q3 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) peaked at $50.3 million during Q4 2021, and registered a low of $48.8 million during Q4 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $49.8 million (2024), whereas its average is $49.8 million.
  • In the last 5 years, Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) rose by 24.93% in 2022 and then crashed by 185.07% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Shares Outstanding (Weighted Average) stood at $50.3 million in 2021, then dropped by 0.76% to $49.9 million in 2022, then fell by 0.36% to $49.7 million in 2023, then dropped by 0.06% to $49.7 million in 2024, then decreased by 1.85% to $48.8 million in 2025.
  • Its last three reported values are $48.8 million in Q4 2025, $49.2 million for Q3 2025, and $49.5 million during Q2 2025.